Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
European Review for Medical and Pharmacological Sciences|April 22, 2017
HyalOne® in the treatment of symptomatic hip OA - data from the ANTIAGE register: seven years of observationA Migliore, U Massafra, B Frediani, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|June 10, 2016
Differences Regarding Branded HA in Italy, Part 2: Data from Clinical Studies on Knee, Hip, Shoulder, Ankle, Temporomandibular Joint, Vertebral Facets, and Carpometacarpal JointA Migliore, E Bizzi, O De Lucia, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
A new chance to maintain remission induced by anti-TNF agents in rheumatoid arthritis patients: CYnAR study II of a 12-month follow-upA Migliore, E Bizzi, U Massafra, et al.
International Journal of Immunopathology and Pharmacology|October 15, 2010
Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study)A Migliore, E Bizzi, U Massafra, et al.
European Review for Medical and Pharmacological Sciences|April 26, 2012
May etanercept and PTH (1-34) association heal erosions in early rheumatoid arthritis? A pilot studyA Migliore, U Massafra, E Bizzi, et al.
Arthritis Care & Research|April 19, 2012
Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: a 5-year analysis based on hospitalization recordsP Piscitelli, G Iolascon, G Di Tanna, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 25, 2024
Fetal-hope study: Home monitoring of fetal heart rate in SSA + pregnant women: Rationale and designA Mauro, E Bizzi, C Caccia Dominioni, et al.
International Journal of Immunopathology and Pharmacology|June 10, 2009
The safety of anti-TNF agents in the elderlyA Migliore, E Bizzi, B Laganà, et al.
European Review for Medical and Pharmacological Sciences|July 16, 2013
Safety of intra-articular hip injection of hyaluronic acid products by ultrasound guidance: an open study from ANTIAGE registerA Migliore, S Tormenta, B Laganà, et al.
Frontiers in Immunology|April 3, 2026
Depemokimab and the twice-yearly regimen: pharmacological implications and therapeutic positioning in severe eosinophilic respiratory diseasesA M Marra, E Bizzi, A Gidaro, et al.
Pageof 11